|

EMERGE Mothers and Kids

RECRUITINGSponsored by National University of Ireland, Galway, Ireland
Actively Recruiting
SponsorNational University of Ireland, Galway, Ireland
Started2024-07-09
Est. completion2025-12
Eligibility
Age18 Years – 50 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06327191

Summary

The EMERGE Mothers and Kids study is a follow-up to the EMERGE trial of women with GDM (N=535) that aimed to determine the effect of the addition of metformin compared to placebo on insulin initiation rates, maternal weight gain and perinatal morbidity and mortality. The primary objectives of the EMERGE Mothers and Kids follow up study are: 1. to determine whether treatment with metformin leads to a reduction in maternal disorders of glucose, metabolic syndrome, obesity, hypertension and lipids at up to 10 years post the index pregnancy; 2. to examine the impact of metformin on maternal anxiety, depression, quality of life and breast feeding duration; 3. to examine whether exposure to metformin leads to a reduction in obesity in the offspring at follow up; 4. to determine whether treatment with metformin during pregnancy, in women with GDM, leads to a reduction in adiposity in the offspring at follow up as measured by anthropometric measurements and sum of skinfolds.

Eligibility

Age: 18 Years – 50 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Participation in the original EMERGE trial and consenting to further follow up.

Exclusion Criteria:

* EMERGE trial participants who did not provide consent for further follow up studies.

Conditions2

DiabetesGestational Diabetes

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.